161 related articles for article (PubMed ID: 2498468)
21. Oxazolidinones, a new class of synthetic antituberculosis agent. In vitro and in vivo activities of DuP-721 against Mycobacterium tuberculosis.
Ashtekar DR; Costa-Periera R; Shrinivasan T; Iyyer R; Vishvanathan N; Rittel W
Diagn Microbiol Infect Dis; 1991; 14(6):465-71. PubMed ID: 1802533
[TBL] [Abstract][Full Text] [Related]
22. Two groups of Mycobacterium avium complex strains determined according to the susceptibility to rifampicin and ansamycin.
Tsukamura M
Microbiol Immunol; 1987; 31(7):615-23. PubMed ID: 3125413
[TBL] [Abstract][Full Text] [Related]
23. In vitro susceptibility of Mycobacterium fortuitum, Mycobacterium chelonae and Mycobacterium avium against some quinolones.
Casal M; Rodriguez F; Villalba R; Benavente MC; Gonzalez AI
Chemioterapia; 1987 Dec; 6(6):431-3. PubMed ID: 3481302
[TBL] [Abstract][Full Text] [Related]
24. Mycobacterial plasmids: screening and possible relationship to antibiotic resistance in Mycobacterium avium/Mycobacterium intracellulare.
Franzblau SG; Takeda T; Nakamura M
Microbiol Immunol; 1986; 30(9):903-7. PubMed ID: 3540539
[No Abstract] [Full Text] [Related]
25. New antimycobacterial S-alkylisothiosemicarbazones.
Waisser K; Heinisch L; Slosárek M; Janota J
Folia Microbiol (Praha); 2005; 50(6):479-81. PubMed ID: 16681143
[TBL] [Abstract][Full Text] [Related]
26. Activity of ciprofloxacin and other fluorinated quinolones against mycobacteria.
Young LS; Berlin OG; Inderlied CB
Am J Med; 1987 Apr; 82(4A):23-6. PubMed ID: 3107379
[TBL] [Abstract][Full Text] [Related]
27. Activity of ciprofloxacin against Mycobacteria in vitro: comparison of BACTEC and macrobroth dilution methods.
Trimble KA; Clark RB; Sanders WE; Frankel JW; Cacciatore R; Valdez H
J Antimicrob Chemother; 1987 May; 19(5):617-22. PubMed ID: 3112096
[TBL] [Abstract][Full Text] [Related]
28. Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare.
Fenlon CH; Cynamon MH
Antimicrob Agents Chemother; 1986 Mar; 29(3):386-8. PubMed ID: 2940969
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates.
Krátký M; Bősze S; Baranyai Z; Szabó I; Stolaříková J; Paraskevopoulos G; Vinšová J
Bioorg Med Chem; 2015 Feb; 23(4):868-75. PubMed ID: 25593095
[TBL] [Abstract][Full Text] [Related]
30. Sulfonamide activity against Mycobacterium fortuitum and Mycobacterium chelonei.
Wallace RJ; Jones DB; Wiss K
Rev Infect Dis; 1981; 3(5):898-904. PubMed ID: 7339821
[TBL] [Abstract][Full Text] [Related]
31. In vitro activity of 12 antimicrobial peptides against Mycobacterium tuberculosis and Mycobacterium avium clinical isolates.
Portell-Buj E; Vergara A; Alejo I; López-Gavín A; Monté MR; San Nicolás L; González-Martín J; Tudó G
J Med Microbiol; 2019 Feb; 68(2):211-215. PubMed ID: 30570475
[TBL] [Abstract][Full Text] [Related]
32. Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents.
Wallace RJ; Dalovisio JR; Pankey GA
Antimicrob Agents Chemother; 1979 Nov; 16(5):611-4. PubMed ID: 526002
[TBL] [Abstract][Full Text] [Related]
33. Determination of in vitro susceptibility of mycobacteria to ansamycin.
Heifets LB; Iseman MD
Am Rev Respir Dis; 1985 Sep; 132(3):710-1. PubMed ID: 3929660
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the Efficacy of Novel Oxazolidinone Analogues against Nontuberculous Mycobacteria In Vitro.
Zhao W; Jiang Y; Bao P; Li Y; Tang L; Zhou Y; Zhao Y
Jpn J Infect Dis; 2015; 68(6):520-2. PubMed ID: 25971324
[TBL] [Abstract][Full Text] [Related]
35. Determination of the in vitro susceptibility of 220 Mycobacterium fortuitum isolates to ten antimicrobial agents.
Hernández AM; Arias A; Felipe A; Alvarez R; Sierra A
J Chemother; 1995 Dec; 7(6):503-8. PubMed ID: 8667033
[TBL] [Abstract][Full Text] [Related]
36. [New active drugs against the tuberculosis bacillus and other mycobacteria].
de Kantor IN
Medicina (B Aires); 1986; 46(1):107-12. PubMed ID: 3100907
[No Abstract] [Full Text] [Related]
37. Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin.
Ferro BE; Meletiadis J; Wattenberg M; de Jong A; van Soolingen D; Mouton JW; van Ingen J
Antimicrob Agents Chemother; 2016 Feb; 60(2):1097-105. PubMed ID: 26643335
[TBL] [Abstract][Full Text] [Related]
38. Methods for determining the antimicrobial susceptibility of mycobacteria.
Alcaide F; Esteban J; González-Martin J; Palacios JJ
Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):529-535. PubMed ID: 27236235
[TBL] [Abstract][Full Text] [Related]
39. In vitro activity of antimicrobial agents against mycobacteria.
Casal M; Rodríguez F; Gutierrez J; Ruíz P; Villalba R
Drugs Exp Clin Res; 1988; 14(12):741-5. PubMed ID: 3150951
[TBL] [Abstract][Full Text] [Related]
40. Activity of five fluoroquinolones against Mycobacterium avium-intracellulare complex and M. xenopi.
Rastogi N; Goh KS; David HL
Ann Inst Pasteur Microbiol; 1988; 139(2):233-7. PubMed ID: 3165641
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
